Showing results (91-100 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|October 27, 2018
Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation ServiceKelsey L Hawkins, Jordan King, Thomas Delate, et al.Journal of Managed Care & Specialty Pharmacy|December 24, 2021
Laboratory monitoring to reduce adverse drug-related events: a mixed methods studyTeresa N Harrison, Kristi Reynolds, Erin E Hahn, et al.Journal of Managed Care & Specialty Pharmacy|March 11, 2021
Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysisWinnie W Nelson, Takara A Scott, Mena Boules, et al.Journal of Managed Care & Specialty Pharmacy|February 26, 2014
The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and cautionNancy A Dreyer, Priscilla Velentgas, Kimberly Westrich, et al.Journal of Managed Care & Specialty Pharmacy|March 28, 2019
Economic Evaluation of Anticyclic Citrullinated Peptide Positivity in Rheumatoid ArthritisJaeJin An, Zoe Bider-Canfield, Jenny Kang, et al.Journal of Managed Care & Specialty Pharmacy|March 28, 2019
Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory StudyIbrahim Khilfeh, Eric Guyette, John Watkins, et al.Journal of Managed Care & Specialty Pharmacy|January 17, 2025
Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus - An economic evaluationEugene E Wright, Eden Miller, Anila Bindal, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2025
Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line settingEmma Behan, David L Veenstra, Aasthaa BansalJournal of Managed Care & Specialty Pharmacy|January 2, 2025
Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with schizophrenia in the United StatesVakaramoko Diaby, Shubhram Pandey, Vassiki Sanogo, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2025
Dynamic changes in medication burden leading to fall and hospital readmissions in older adults: Toward a strategy for improving risk and managing costsRafia S Rasu, Christy Xavier, Nahid RianonPageof 185